肺腺癌脑膜转移患者的预后分析
发布时间:2018-05-24 12:22
本文选题:癌 + 非小细胞肺 ; 参考:《肿瘤》2017年04期
【摘要】:目的:探讨肺腺癌脑膜转移患者的生存情况及预后相关因素。方法:回顾性分析65例随访资料完整的肺腺癌脑膜转移患者的生存情况及预后相关因素。结果:65例患者的中位生存期为7.4个月,1年生存率为6.2%(4/65)。单因素分析结果显示,性别、年龄、吸烟史、脑膜转移时间及是否合并脑转移与总生存无显著相关性(P值均0.05),美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)体能状况(performance status,PS)评分、是否接受脑室-腹腔(ventriculo-peritoneal,V-P)分流手术、表皮生长因子受体-酪氨酸激酶抑制剂(epidermal growth factor receptortyrosine kinase inhibitor,EGFR-TKI)靶向治疗、全身化疗(systemic chemotherapy,SC)、全脑放疗、脑膜转移时的临床症状和EGFR基因状态与总生存显著相关(P值均0.05)。多因素分析结果显示,EGFR基因状态、ECOG PS评分、SC和是否接受V-P分流手术是肺腺癌脑膜转移患者的独立预后因素(P值均0.05)。结论:肺腺癌脑膜转移患者的总体预后较差,其中EGFR基因突变患者的预后相对较好;EGFR-TKI靶向治疗、SC和V-P分流手术有助于延长肺腺癌脑膜转移患者的生存期,改善其预后。
[Abstract]:Objective: to investigate the survival and prognostic factors of patients with meningeal metastasis from lung adenocarcinoma. Methods: the survival and prognostic factors of 65 patients with meningeal metastasis from lung adenocarcinoma were retrospectively analyzed. Results the median survival time of 65 patients was 7.4 months and the 1 year survival rate was 6. 2 / 65. The results of univariate analysis showed that gender, age, smoking history, meningeal metastasis time and brain metastasis had no significant correlation with total survival (P = 0.05). Whether or not to undergo ventricular / peritoneal ventriculo-peritoneal V-P shunt, epidermal growth factor receptortyrosine kinase inhibitor EGFR-TKI, systemic chemotherapy, whole brain radiotherapy, The clinical symptoms and EGFR gene status of meningeal metastasis were significantly correlated with total survival (P = 0.05). Multivariate analysis showed that EGFR gene status, ECOG PS score, SC and V-P shunt were independent prognostic factors in patients with meningeal metastasis of lung adenocarcinoma. Conclusion: the overall prognosis of patients with meningeal metastasis from lung adenocarcinoma is poor. The prognosis of patients with EGFR gene mutation is relatively good. Conclusion: EGFR-TKI targeted therapy of SC and V-P shunt surgery can prolong the survival time and improve the prognosis of patients with meningeal metastasis of lung adenocarcinoma.
【作者单位】: 郑州大学人民医院肿瘤内科;郑州大学人民医院神经外科;郑州大学人民医院放射科;郑州大学人民医院放疗科;郑州大学人民医院胸外科;
【分类号】:R734.2
【参考文献】
相关博士学位论文 前1条
1 郭海生;EGFR基因多态性与肺腺癌胸膜转移的相关性及特罗凯在肺腺癌胸膜转移性胸腔积液中的应用[D];山东大学;2012年
【相似文献】
相关期刊论文 前4条
1 邵志坚,何泽明,金小民,杨春盛;肺腺癌脑膜转移2例[J];临床肿瘤学杂志;1999年02期
2 王勇;高烨;许德志;朱玉方;徐军;王秀华;陶荣杰;;经Ommaya囊脑室内化学治疗肺腺癌脑膜转移[J];中国临床神经外科杂志;2013年04期
3 赵海涛;王勇;许德志;朱玉方;徐军;陶荣杰;;脑室腹腔分流加Ommaya囊置入配合放化疗治疗肺腺癌脑膜转移的临床观察[J];肿瘤防治研究;2013年10期
4 ;[J];;年期
,本文编号:1929032
本文链接:https://www.wllwen.com/yixuelunwen/zlx/1929032.html